1. Home
  2. GNSS vs BDSX Comparison

GNSS vs BDSX Comparison

Compare GNSS & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genasys Inc.

GNSS

Genasys Inc.

HOLD

Current Price

$1.90

Market Cap

101.7M

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$16.43

Market Cap

122.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNSS
BDSX
Founded
1992
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Precision Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
101.7M
122.0M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
GNSS
BDSX
Price
$1.90
$16.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$4.75
$32.50
AVG Volume (30 Days)
131.3K
136.8K
Earning Date
01-01-0001
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
44.44
N/A
EPS
N/A
N/A
Revenue
$26,306,790.00
$88,499,000.00
Revenue This Year
$78.94
$23.35
Revenue Next Year
N/A
$19.33
P/E Ratio
N/A
N/A
Revenue Growth
29.50
24.08
52 Week Low
$1.46
$0.25
52 Week High
$2.70
$20.21

Technical Indicators

Market Signals
Indicator
GNSS
BDSX
Relative Strength Index (RSI) 47.07 57.36
Support Level $1.87 $6.33
Resistance Level $2.11 N/A
Average True Range (ATR) 0.10 1.91
MACD 0.00 -0.10
Stochastic Oscillator 48.90 53.31

Price Performance

Historical Comparison
GNSS
BDSX

About GNSS Genasys Inc.

Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: